Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 23:43 PM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for VX1

VERTEX quote and profile

    
47.23
  
STOCK
 1.14   Macroaxis: 2.47 Up   2.47%  
 20.03 Year To Date 40.6 
 50.9 Trading Day  50.9 

Diversification Suggestion

Use VERTEX to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals

1 Month Beta ..........

-2.22
As returns on market increase, returns on owning VERTEX are expected to decrease by larger amounts. On the other hand, during market turmoil, VERTEX is expected to significantly outperform it.
VERTEX PHARMACEUTIC Large Negative Beta
VX1 Germany Berlin #US92532F1003DE
VERTEX PHARMACEUTIC
 
Trade VERTEX
 thisGreen VX1 VX1.BE agains markets  2.47 % Macroaxis: change 2.47 Moved Up  
 
 United States NASDAQ   0.07 % Macroaxis: 0.07 Moved Down  
 
 United States SP 500   0.22 % Macroaxis: 0.22 Moved Down  
 
 United States NYSE   0.24 % Macroaxis: 0.24 Moved Down  
 

VERTEX correlation with market

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding VERTEX PHARMACEUTIC and equity matching NYA index in the same portfolio

VERTEX Performance

    
Price Growth (%)   
VERTEX  Market  
 
Timeline
    

VERTEX 30-Days Risk-Return Take

    
If you would invest 2,906 in VERTEX PHARMACEUTIC on April 26, 2012 and sell it today you would earn a total of 1,900 from holding VERTEX PHARMACEUTIC or generate 65.38% return on investment over 30 days. VERTEX PHARMACEUTIC is generating 5.06% of daily returns assuming 12.15% volatility of returns over the 30 days investment horizon. Simply put, majority of traded equity instruments are less risky than VERTEX PHARMACEUTIC on the bases of their historical return distribution and most equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Assuming 30 trading days horizon, VERTEX PHARMACEUTIC is expected to generate 16.64 times more return on investment than the market. However, the company is 16.64 times more volatile than its market benchmark. It trades about 0.42 of its potential returns per unit of risk. The NYSE is currently generating roughly -0.47 per unit of risk.
    

Discuss VERTEX quote and profile

       
       
    
    
VERTEX
Performance
18
Out Of
100
Over 30
Days
82% of all equities and portfolios perform better than VERTEX PHARMACEUTIC. Compared with the overall equity markets, risk-adjusted returns on investments in VERTEX PHARMACEUTIC are ranked lower than 18 (%) of all global equities and portfolios over the last 30 days.
    
    

Promote VERTEX

    
Follow VERTEX with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add VERTEX to your reader
 
Get social with VERTEX
 Get social with VERTEX 
Share Toggle social options for VERTEX
    

Add VERTEX to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

VERTEX Research Report

    
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting